Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-17 is a cap-dependent endonuclease (CEN) inhibitor. Cap-dependent endonuclease-IN-17 shows antiviral activity against influenza virus A/Hanfang/359/95 (H3N2) with IC50 of 1.29 μM (CN112898346A; DSC701)[1].
Web ID
– HY-143771
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C24H20F2N3O7PS
References
– [1]Zhefeng, Zhang, et al. Water-soluble polycyclic compound, and pharmaceutical composition and application thereof. CN112898346A.
CAS Number
– 2649362-71-8
Molecular Weight
– 563.47
SMILES
– O=C1N2[C@](COCC2)([H])N([C@@H]3C4=CC=CC=C4SCC5=C(F)C(F)=CC=C35)N6C1=C(OP(O)(O)=O)C(C=C6)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
